Lilly opens state-of-the-art research and development center in the Boston Seaport
Eli Lilly and Company announced the opening of the Lilly Seaport Innovation Center (LSC), a research and development facility in...
Eli Lilly and Company announced the opening of the Lilly Seaport Innovation Center (LSC), a research and development facility in...
Daiichi Sankyo and MSD have widened their partnership to create and market three DXd-based antibody-drug conjugates (ADCs) all over the...
For an option on Biocytogen Pharmaceuticals’ possible first-in-class B7H3/PTK7 BsADC program, Ideaya Biosciences is paying more than $400 million. The...
The largest pharmaceutical company in the world based on market value, Eli Lilly, is getting into the nuclear isotope manufacturing...
The life sciences industry is going through a big change right now, thanks to the fast growth of new treatments...
Research, cooperation, and the sustainability of safe radiopharmaceuticals for clinical application will be aided by a new IAEA radiopharmacy database....
ADCs could lead to better and more efficient treatments in the complex and specialized field of tailored cancer medicines. ADCs...
Beyond cancer, there are a number of sectors that provide considerable prospects for antibody drug conjugates (ADCs), using their capacity...
Antibody drug conjugates (ADCs) are the main players in the fields of cancer clinical research and deal-making, with new alliances...
The pharmaceutical water market is expected to grow at a compound annual growth rate (CAGR) of 9.3% from 2024 to...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.